Suchergebnisse - "Kimmoun, Antoine"

PubPharm (290)

71

Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19

enthalten in: The Lancet. Infectious diseases | 2022

von Ader, F. | Bouscambert-Duchamp, M. | Hites, M. | +104

72

Soluble triggering receptor expressed on myeloid cells-1 is a marker of organ injuries in cardiogenic shock : results from the CardShock Study

enthalten in: Clinical research in cardiology : official journal of the German Cardiac Society | 2022

von Kimmoun, A. | Duarte, K. | Harjola, V. | +59

73

Early echocardiography by treating physicians and outcome in the critically ill : An ancillary study from the prospective multicenter trial FROG-ICU

enthalten in: Journal of critical care | 2022

von Takagi, K. | Akiyama, E. | Paternot, A. | +19

CommentIn: J Crit Care. 2022 Dec;72:154159. - PMID 36155961

74

Extracorporeal Membrane Oxygenation for Respiratory Failure Related to COVID-19 : A Nationwide Cohort Study

enthalten in: Anesthesiology | 2022

von Nesseler, N. | Fadel, G. | Mansour, A. | +126

75

Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

enthalten in: bioRxiv.org | 2022

von Ader, F. | Bouscambert-Duchamp, M. | Hites, M. | +70

76

Single-dose tocilizumab blunts systemic inflammation in severe COVID-19 patients

enthalten in: Journal of critical care | 2022

von de Roquetaillade, C. | Guillemin, J. | Picod, A. | +4

77

Amniotic fluid embolism rescued by venoarterial extracorporeal membrane oxygenation

enthalten in: Critical care (London, England) | 2022

von Aissi James, S. | Klein, T. | Lebreton, G. | +10

78

Amniotic fluid embolism rescued by venoarterial extracorporeal membrane oxygenation

enthalten in: Critical care | 2022

von Aissi James, S. | Klein, T. | Lebreton, G. | +10

79

An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 – Final results from the DisCoVeRy trial

enthalten in: bioRxiv.org | 2022

von Ader, F. | Peiffer-Smadja, N. | Poissy, J. | +55

80

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy) : a phase 3, randomised, controlled, open-label trial

enthalten in: The Lancet. Infectious diseases | 2022

von Ader, F. | Bouscambert-Duchamp, M. | Hites, M. | +115

CommentIn: Lancet Infect Dis. 2021 Sep 14;:null. - PMID 34534513